These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26744430)

  • 1. Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997-2013.
    Head MG; Fitchett JR; Lichtman AB; Soyode DT; Harris JN; Atun R
    J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S3-7. PubMed ID: 26744430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
    Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
    EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013.
    Head MG; Fitchett JR; Derrick G; Wurie FB; Meldrum J; Kumari N; Beattie B; Counts CJ; Atun R
    Health Res Policy Syst; 2015 Nov; 13():63. PubMed ID: 26537547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.
    Head MG; Fitchett JR; Atun R; May RC
    BMJ Open; 2014 Jan; 4(1):e004129. PubMed ID: 24413353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010.
    Head MG; Fitchett JR; Atun R
    J R Soc Med; 2014 Mar; 107(3):110-5. PubMed ID: 24262891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
    Head MG; Brown RJ; Clarke SC
    J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010.
    Fitchett JR; Head MG; Cooke MK; Wurie FB; Atun R
    PLoS One; 2014; 9(8):e105722. PubMed ID: 25162631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
    Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Lipman MC; Atun R
    BMJ Open; 2014 Mar; 4(3):e004600. PubMed ID: 24670431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norovirus in 2016-Emesis Aplenty but Clear Signs of Progress.
    Head MG; Lopman BA
    J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S1-2. PubMed ID: 26744425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
    Fitchett JR; Head MG; Atun R
    Vaccine; 2013 Dec; 31(50):5930-3. PubMed ID: 24176489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
    Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
    Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
    Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
    BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom.
    Tam CC; O'Brien SJ
    PLoS One; 2016; 11(2):e0138526. PubMed ID: 26828435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
    Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
    Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions.
    Head MG; Fitchett JR; Cassell JA; Atun R
    J Glob Health; 2015 Dec; 5(2):020405. PubMed ID: 26322229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010.
    Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R; Hayward AC; Holmes A; Johnson AP; Woodford N
    J Antimicrob Chemother; 2014 Feb; 69(2):548-54. PubMed ID: 24038777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
    Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
    EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.
    McIntosh SA; Alam F; Adams L; Boon IS; Callaghan J; Conti I; Copson E; Carson V; Davidson M; Fitzgerald H; Gautam A; Jones CM; Kargbo S; Lakshmipathy G; Maguire H; McFerran K; Mirandari A; Moore N; Moore R; Murray A; Newman L; Robinson SD; Segaran A; Soong CN; Walker A; Wijayaweera K; Atun R; Cutress RI; Head MG
    Lancet Oncol; 2023 Jun; 24(6):636-645. PubMed ID: 37269844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010.
    Head MG; Fitchett JR; Cooke GS; Foster GR; Atun R
    J Viral Hepat; 2015 Mar; 22(3):230-7. PubMed ID: 25146854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Economic Burden of Norovirus Gastroenteritis.
    Bartsch SM; Lopman BA; Ozawa S; Hall AJ; Lee BY
    PLoS One; 2016; 11(4):e0151219. PubMed ID: 27115736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.